These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35068536)

  • 1. Leukotriene Antagonists in Dermatology.
    Bubna AK
    Indian J Dermatol; 2021; 66(5):575. PubMed ID: 35068536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of leukotriene modifiers in asthma: a review of clinical experience.
    Reques FG; Rodriguez JL
    BioDrugs; 1999 Jun; 11(6):385-94. PubMed ID: 18031150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review.
    Di Lorenzo G; D'Alcamo A; Rizzo M; Leto-Barone MS; Bianco CL; Ditta V; Politi D; Castello F; Pepe I; Di Fede G; Rini G
    J Asthma Allergy; 2008 Dec; 2():9-16. PubMed ID: 21437139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives for asthma treatment: anti-leukotriene drugs.
    García-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for antileukotrienes in urticaria?
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito-Pellitteri M; Ditta V; Lo Bianco C; Leto-Barone MS; Di Fede G; Rini GB
    Clin Exp Dermatol; 2006 May; 31(3):327-34. PubMed ID: 16681569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in therapy with antileukotriene drugs.
    Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
    Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma.
    Coreno A; Skowronski M; Kotaru C; McFadden ER
    J Allergy Clin Immunol; 2000 Sep; 106(3):500-6. PubMed ID: 10984370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ; David-Bajar K
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
    Kelloway JS
    Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
    Yanes DA; Mosser-Goldfarb JL
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New horizons in the treatment of atopic dermatitis].
    Ortiz de Frutos FJ
    Allergol Immunopathol (Madr); 2002; 30(3):134-40. PubMed ID: 11988144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive Effect of Leukotriene Antagonists on Capsular Contracture in Patients Who Underwent Breast Surgery with Prosthesis: A Meta-Analysis.
    Wang Y; Tian J; Liu J
    Plast Reconstr Surg; 2020 Apr; 145(4):901-911. PubMed ID: 32221199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field.
    Nettis E; D'Erasmo M; Di Leo E; Calogiuri G; Montinaro V; Ferrannini A; Vacca A
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20886028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
    Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
    Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileukotrienes in asthma: present situation.
    García-Marcos L; Schuster A
    Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
    Piromkraipak P; Parakaw T; Phuagkhaopong S; Srihirun S; Chongthammakun S; Chaithirayanon K; Vivithanaporn P
    Can J Physiol Pharmacol; 2018 Aug; 96(8):798-806. PubMed ID: 29726704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review on the off-label use of montelukast in atopic dermatitis treatment.
    Chin WK; Lee SWH
    Int J Clin Pharm; 2018 Oct; 40(5):963-976. PubMed ID: 29777328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.
    Dellaripa PF; Wechsler ME; Roth ME; Drazen J
    Mayo Clin Proc; 2000 Jun; 75(6):643-5. PubMed ID: 10852428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.